ウサギの診断市場2022 - サイズ、成長、傾向 2030年までに

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of rabies diagnostic
1.5.Rabies Diagnostics Market: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in Brief
1.9.Parent Market Overview
1.10. Rabies Diagnostic Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average Primary Breakdown Ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact Forces on Market Dynamics
2.3.2.Impact Forces During the Forecast Years
2.4.Industry Value Chain
2.4.1.Upstream Analysis
2.4.2.Downstream Analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Porter\'s Analysis
2.9.1.Supplier Power
2.9.2.Buyer Power
2.9.3.Substitution Threat
2.9.4.Threat from New Entry
2.9.5.Competitive Rivalry
2.10. PESTEL Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technological Factors
2.10.5. Environmental Factors
2.10.6. Legal Factors

3.Rabies Diagnostics Market Segmentation, by Revenue (USD Million), (2023-2030)

3.1.By Test Type
3.1.1.Fluorescent Antibody Test (FAT)
3.1.2.Immunohistochemical Test
3.1.3.Amplification Methods
3.1.4.Histologic Examination
3.1.5.Serology Tests
3.1.6.Mouse Inoculation Test
3.2.By Technology
3.2.1.ELISA
3.2.2.PCR
3.2.3.Chromatography Techniques
3.2.4.Others
3.3.By End User
3.3.1.Hospitals
3.3.2.Diagnostic centers
3.3.3.Cancer Palliative care clinics
3.3.4.Others

4.Rabies Diagnostics Market Overview, By Region

4.1. North America Rabies Diagnostics Market Revenue (USD Million), by Countries, (2023-2030)
4.1.1. U.S.
4.1.1.1.By Test Type
4.1.1.2.By Technology
4.1.1.3.By End User
4.1.2.Canada
4.1.3.Mexico
4.2.Rabies Diagnostics Market Revenue (USD Million), by Countries, (2023-2030)
4.2.1.Germany
4.2.2.France
4.2.3.UK
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Rabies Diagnostics Market Revenue (USD Million), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASEAN
4.4.Latin America Rabies Diagnostics Market Revenue (USD Million), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Rabies Diagnostics Market Revenue (USD Million), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Rabies Diagnostics Market Revenue: Competitive Analysis, 2022

5.1.Key Strategies by Players
5.2.Revenue (USD Million) and Market Share (%), By Manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Bio-Rad Laboratories
6.1.1.Business Overview
6.1.2.Business Financials (USD Million)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.SWOT Analysis
6.2.Merck KGaA
6.3.Aviva Systems Biology
6.4.Creative Diagnostics
6.5.MyBioSource
6.6.Abbexa Ltd
6.7. Norgen Biotek
6.8.EXPRESS BIOTECH INTERNATIONAL, INC

7.Market Research Findings & Conclusion

Disclaimer